| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.5M | +101.9% |
| SG&A Expense | $4.7M | +104.3% |
| Operating Income | -$14.5M | -104.8% |
| Interest Expense | $44K | — |
| Net Income | -$22.6M | -218.4% |
| EPS (Basic) | $68.44 | — |
| EPS (Diluted) | $68.44 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.6M | +25.0% |
| Current Assets | $5.8M | +18.5% |
| Total Assets | $5.9M | +20.9% |
| Current Liabilities | $1.3M | -15.7% |
| Total Liabilities | $18.9M | +1008.4% |
| Stockholders' Equity | -$13.0M | -506.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | -90.5% |
| Capital Expenditures | $104K | — |
| Investing Cash Flow | -$104K | — |
| Financing Cash Flow | $13.7M | +57.4% |
| Free Cash Flow | -$12.6M | — |